Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
|Product:||Betadine Sore Throat Gargle|
|Active Ingredients:||Ethanol 30.543%w/v Povidone-iodine 7.5%w/v equivalent to iodine 0.75%|
|New Zealand Sponsor:||Sanofi-Aventis New Zealand limited|
|Manufacturer:||Mayne Pharma International Pty Limited, Adelaide, Australia|
|Active Ingredient:||Dexamfetamine sulfate 5mg|
|New Zealand Sponsor:||PSM Healthcare Limited trading as API Consumer Brands|
|Manufacturer:||PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand|
|Active Ingredient:||Zinc oxide 15.25%w/w|
|Dosage Form:||Topical cream|
|New Zealand Sponsor:||Nice-Pak Products (NZ) Limited|
|Manufacturer:||Tosara Pharma Limited, Baldoyle, Ireland|
Dated this 6th day of July 2020.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).